Gary Acton

发表

ZPLOTIT Software Users' Guide

Gary Acton, 2011 .

Machine Learning and Deep Learning Applications for International Ocean Discovery Program Geoscience Research

Gary Acton, Brandon De La Houssaye, Peter Flaming, 2019 .

VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia

Michael Craig, Robert K. Stuart, Gary Acton, 2012 .

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.

Arnaud Pigneux, Gary Acton, Michael Heuser, 2015, The Lancet. Oncology.